Lipocine Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP’RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
/ 
Frequently asked questions
To buy Lipocine Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lipocine Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lipocine Inc. is LPCN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lipocine Inc. has its primary listing on NASDAQ (Small cap). You can trade Lipocine Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lipocine Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lipocine Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lipocine Inc..